Artificial Intelligence (AI) In Clinical Trials Global Market Report 2025

Description

The application of artificial intelligence in clinical trials involves utilizing AI to enhance the efficiency and adequacy of trial designs. AI is employed in clinical trials to optimize trial processes by making predictions regarding patient behavior and drug efficacy.

The primary offerings of AI in clinical trials encompass both software and services. Software solutions involve the development or configuration of customized solutions to address specific challenges. Artificial intelligence software is utilized to facilitate quicker and more accurate hypothesis generation and to gain insights into disease progression. These applications extend to various stages of the clinical trial process, including trial design, patient selection, site selection, and patient monitoring across a range of medical fields such as oncology, neurological diseases, cardiovascular diseases, metabolic diseases, infectious diseases, and immunology diseases. The beneficiaries of AI in clinical trials include pharmaceutical and biotechnology companies, contract research organizations, and other relevant stakeholders.

The artificial intelligence (AI) in clinical trials research report is one of a series of new reports from The Business Research Company that provides artificial intelligence (AI) in clinical trials market statistics, including the artificial intelligence (AI) in clinical trials industry's global market size, regional shares, competitors with an artificial intelligence (AI) in clinical trials market share, detailed artificial intelligence (AI) in clinical trials market segments, market trends and opportunities, and any further data you may need to thrive in the artificial intelligence (AI) in clinical trials industry. This artificial intelligence (AI) in clinical trials market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The artificial intelligence (AI) in clinical trials market size has grown exponentially in recent years. It will grow from $7.19 billion in 2024 to $10.14 billion in 2025 at a compound annual growth rate (CAGR) of 41.1%. The growth in the historic period can be attributed to increasing data complexity, rising costs and time constraints, regulatory demands, early ai applications, patient-centric approaches

The artificial intelligence (AI) in clinical trials market size is expected to see exponential growth in the next few years. It will grow to $38.03 billion in 2029 at a compound annual growth rate (CAGR) of 39.2%. The growth in the forecast period can be attributed to personalized medicine emphasis, real-time monitoring solutions, remote trial execution, risk prediction and mitigation, expanded data sources integration. Major trends in the forecast period include adaptive trial design, natural language processing (NLP) in data analysis, ai-driven patient recruitment, blockchain integration for data security, predictive analytics for patient outcomes.

The anticipated growth in the artificial intelligence clinical trial market is driven by the growing imperative to control clinical trial costs. Clinical trials, which evaluate medical, surgical, or behavioral interventions in individuals, incur expenses related to research and patient care. The inherently costly nature of drug development and other clinical trial processes has led to the application of artificial intelligence for more efficient drug discovery, the creation of better-designed and safer clinical trials, and improved patient outcomes-all at reduced costs. For instance, a February 2023 report from Genetic Engineering and Biotechnology News highlighted a 15% increase in the cost of developing a new drug among the top 20 global biopharma companies, rising from $298 million in 2022 to approximately $2.3 billion in 2023. This cost encompasses expenses incurred during drug development, including clinical trials. Additionally, a January 2023 report from the National Bureau of Economic Research projected significant cost savings in healthcare-ranging from 5 to 10% of healthcare spending, translating to approximately $200 billion to $360 billion in annual savings-attributed to the adoption of AI within the next five years. Hence, the imperative to control clinical trial costs is expected to drive the artificial intelligence clinical trial market.

The factor expected to drive the growth of artificial intelligence in the clinical trial market is the increasing volume of research and development activities. Research and Development (R&D) activities involve a systematic process of investigation, experimentation, and innovation conducted by organizations or individuals to create new products, processes, or knowledge. Artificial Intelligence (AI) significantly contributes to various facets of R&D activities in the context of clinical trials, including the analysis of diverse datasets, implementation of adaptive trial designs, and streamlining administrative processes. For instance, a May 2023 report from Xtalks noted an increase in the R&D pipeline for drugs from 18,582 in 2021 to over 20,109 drugs in 2022. Furthermore, the global count of registered clinical trials surged to 452,604 in 2023, marking a substantial rise from the reported figure of over 365,000 trials in 2021. Consequently, the escalating number of research and development activities is expected to propel the artificial intelligence clinical trial market's growth.

An emerging trend in the artificial intelligence in clinical trial market is the introduction of innovative product offerings. Leading companies in this market have unveiled novel products to maintain their competitive standing. For example, in January 2023, Elligo Health Research Inc., a healthcare-enabling research organization based in the US, rolled out DataAI Connect. This groundbreaking data and technology platform facilitate swift, data-driven clinical research by seamlessly collecting, managing, evaluating, and sharing real-world patient data. unlike as mere supplementary technology, this adaptable and sustainable platform presents a comprehensive strategy to overcome clinical trial challenges. It features an all-in-one solution for retrieving and assessing medical records, utilizing cutting-edge technologies such as Natural Language Processing (NLP), Machine Learning (ML), and clinical expertise to transform data into actionable insights and individual patient progress information.

Major players in the artificial intelligence in clinical trials market are directing their efforts toward developing innovative technologies such as AI feasibility and recruitment platforms. These platforms leverage artificial intelligence (AI) to evaluate the viability and potential success of clinical trials, while also aiding in the efficient recruitment of suitable participants. For instance, in June 2023, a US-based research provider company unveiled 'ObjectiveScreen,' an AI-powered feasibility and recruitment platform that enhances clinical trial performance and outcomes by improving patient identification, prequalification, and retention processes. ObjectiveScreen establishes direct connectivity between clinical trial sites and the electronic health records (EHRs) of patients, promoting patient engagement through simplified and streamlined appointment scheduling and communication processes.

In January 2023, Paradigm Health Inc., a US-based healthcare technology company, acquired Deep Lens Inc. The acquisition is geared towards providing Paradigm with Deep Lens's platform, which ensures equal access to trials for all patients while enhancing trial efficiency and reducing barriers to participation for healthcare providers. Deep Lens Inc., based in the US, is a provider of an AI-driven cloud platform for clinical research.

Major companies operating in the artificial intelligence (AI) in clinical trials market include Medable Inc., PathAI inc., Saama Technologies Inc., TriNetX LLC, SymphonyAI Summit Inc., Aktana, Nference Inc., Insilico Medicine Inc., Vineti Inc., Innoplexus AG, Healx, AiCure Inc., MEDIAN Technologies SA, Owkin Inc., Science 37, Ardigen SA, Cyft Inc., Unlearn.AI Inc., Mendel AI, Deep Lens Inc., Antidote Technologies Inc., Arterys Inc., Euretos BV, Halo Health Systems Inc., Trials.Ai Inc., Transparency Life Sciences, BioAge Labs Inc., Wave Life Sciences Ltd., BioSymetrics Inc.

North America was the largest region in the artificial intelligence (AI) in clinical trials market in 2024. North America is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence (ai) in clinical trials market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the artificial intelligence (ai) in clinical trials market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The artificial intelligence (AI) in clinical trials market consists of revenues earned by entities by providing artificial intelligence in clinical trials services that include data security and compliance services and consulting and implementation services. The market value includes the value of related goods sold by the service provider or included within the service offering. The artificial intelligence (AI) in the clinical trials market also includes sales of clinical trial matching software, patient recruitment software and medical image analysis software. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Artificial Intelligence (AI) In Clinical Trials Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on artificial intelligence (ai) in clinical trials market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for artificial intelligence (ai) in clinical trials ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The artificial intelligence (ai) in clinical trials market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Offering: Software; Services
2) By Process: Trial Design; Patient Selection; Site Selection; Patient Monitoring
3) By Application: Oncology; Neurological Disease And Condition; Cardiovascular Disease; Metabolic Disease; Infectious Disease; Immunology Disease; Other Applications
4) By End-User: Pharmaceutical And Biotechnology Company; Contract Research Organizations; Other End-Users
Subsegments:
1) By Software: AI-driven Analytics Platforms; Data Management Tools; Patient Recruitment Solutions; Predictive Modeling Software
2) By Services: Consulting Services; Data Annotation And Labeling Services; Custom AI Model Development; Implementation And Integration Services
Companies Mentioned: Medable Inc.; PathAI inc.; Saama Technologies Inc.; TriNetX LLC; SymphonyAI Summit Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r24677

1. Executive Summary

2. Artificial Intelligence (AI) In Clinical Trials Market Characteristics

3. Artificial Intelligence (AI) In Clinical Trials Market Trends And Strategies

4. Artificial Intelligence (AI) In Clinical Trials Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

5. Global Artificial Intelligence (AI) In Clinical Trials Growth Analysis And Strategic Analysis Framework

5.1. Global Artificial Intelligence (AI) In Clinical Trials PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Artificial Intelligence (AI) In Clinical Trials Market Growth Rate Analysis
5.4. Global Artificial Intelligence (AI) In Clinical Trials Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Artificial Intelligence (AI) In Clinical Trials Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Artificial Intelligence (AI) In Clinical Trials Total Addressable Market (TAM)

6. Artificial Intelligence (AI) In Clinical Trials Market Segmentation

6.1. Global Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Software
Services
6.2. Global Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Trial Design
Patient Selection
Site Selection
Patient Monitoring
6.3. Global Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oncology
Neurological Disease And Condition
Cardiovascular Disease
Metabolic Disease
Infectious Disease
Immunology Disease
Other Applications
6.4. Global Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Pharmaceutical And Biotechnology Company
Contract Research Organizations
Other End-Users
6.5. Global Artificial Intelligence (AI) In Clinical Trials Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
AI-driven Analytics Platforms
Data Management Tools
Patient Recruitment Solutions
Predictive Modeling Software
6.6. Global Artificial Intelligence (AI) In Clinical Trials Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Consulting Services
Data Annotation And Labeling Services
Custom AI Model Development
Implementation And Integration Services

7. Artificial Intelligence (AI) In Clinical Trials Market Regional And Country Analysis

7.1. Global Artificial Intelligence (AI) In Clinical Trials Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Artificial Intelligence (AI) In Clinical Trials Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Artificial Intelligence (AI) In Clinical Trials Market

8.1. Asia-Pacific Artificial Intelligence (AI) In Clinical Trials Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Artificial Intelligence (AI) In Clinical Trials Market

9.1. China Artificial Intelligence (AI) In Clinical Trials Market Overview
9.2. China Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Artificial Intelligence (AI) In Clinical Trials Market

10.1. India Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Artificial Intelligence (AI) In Clinical Trials Market

11.1. Japan Artificial Intelligence (AI) In Clinical Trials Market Overview
11.2. Japan Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Artificial Intelligence (AI) In Clinical Trials Market

12.1. Australia Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Artificial Intelligence (AI) In Clinical Trials Market

13.1. Indonesia Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Artificial Intelligence (AI) In Clinical Trials Market

14.1. South Korea Artificial Intelligence (AI) In Clinical Trials Market Overview
14.2. South Korea Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Artificial Intelligence (AI) In Clinical Trials Market

15.1. Western Europe Artificial Intelligence (AI) In Clinical Trials Market Overview
15.2. Western Europe Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Artificial Intelligence (AI) In Clinical Trials Market

16.1. UK Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Artificial Intelligence (AI) In Clinical Trials Market

17.1. Germany Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Artificial Intelligence (AI) In Clinical Trials Market

18.1. France Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Artificial Intelligence (AI) In Clinical Trials Market

19.1. Italy Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Artificial Intelligence (AI) In Clinical Trials Market

20.1. Spain Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Artificial Intelligence (AI) In Clinical Trials Market

21.1. Eastern Europe Artificial Intelligence (AI) In Clinical Trials Market Overview
21.2. Eastern Europe Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Artificial Intelligence (AI) In Clinical Trials Market

22.1. Russia Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Artificial Intelligence (AI) In Clinical Trials Market

23.1. North America Artificial Intelligence (AI) In Clinical Trials Market Overview
23.2. North America Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Artificial Intelligence (AI) In Clinical Trials Market

24.1. USA Artificial Intelligence (AI) In Clinical Trials Market Overview
24.2. USA Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Artificial Intelligence (AI) In Clinical Trials Market

25.1. Canada Artificial Intelligence (AI) In Clinical Trials Market Overview
25.2. Canada Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Artificial Intelligence (AI) In Clinical Trials Market

26.1. South America Artificial Intelligence (AI) In Clinical Trials Market Overview
26.2. South America Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Artificial Intelligence (AI) In Clinical Trials Market

27.1. Brazil Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Artificial Intelligence (AI) In Clinical Trials Market

28.1. Middle East Artificial Intelligence (AI) In Clinical Trials Market Overview
28.2. Middle East Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Artificial Intelligence (AI) In Clinical Trials Market

29.1. Africa Artificial Intelligence (AI) In Clinical Trials Market Overview
29.2. Africa Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Artificial Intelligence (AI) In Clinical Trials Market Competitive Landscape And Company Profiles

30.1. Artificial Intelligence (AI) In Clinical Trials Market Competitive Landscape
30.2. Artificial Intelligence (AI) In Clinical Trials Market Company Profiles
- 30.2.1. Medable Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. PathAI inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Saama Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. TriNetX LLC Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. SymphonyAI Summit Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Artificial Intelligence (AI) In Clinical Trials Market Other Major And Innovative Companies

31.1. Aktana
31.2. Nference Inc.
31.3. Insilico Medicine Inc.
31.4. Vineti Inc.
31.5. Innoplexus AG
31.6. Healx
31.7. AiCure Inc.
31.8. MEDIAN Technologies SA
31.9. Owkin Inc.
31.10. Science 37
31.11. Ardigen SA
31.12. Cyft Inc.
31.13. Unlearn.AI Inc.
31.14. Mendel AI
31.15. Deep Lens Inc.

32. Global Artificial Intelligence (AI) In Clinical Trials Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Artificial Intelligence (AI) In Clinical Trials Market

34. Recent Developments In The Artificial Intelligence (AI) In Clinical Trials Market

35. Artificial Intelligence (AI) In Clinical Trials Market High Potential Countries, Segments and Strategies

35.1 Artificial Intelligence (AI) In Clinical Trials Market In 2029 - Countries Offering Most New Opportunities
35.2 Artificial Intelligence (AI) In Clinical Trials Market In 2029 - Segments Offering Most New Opportunities
35.3 Artificial Intelligence (AI) In Clinical Trials Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer